|1.19||-0.01 / -0.83%|
Data as of 4:00pm ET
|1.10||-0.09 / -7.56%|
The 3 analysts offering 12-month price forecasts for Aveo Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 1.00. The median estimate represents a +68.07% increase from the last price of 1.19.
The current consensus among 5 polled investment analysts is to Hold stock in Aveo Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.